Back to Search
NEAL READY, MD
MD
Medical Oncology Physician
NPI: 1932156197IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
2006-00308(NC)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
VANDERBILT UNIVERSITY SCHOOL OF MEDICINE
Class of 1986
Research & Publications (20)
Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors.
PMID 17255280·Clin Cancer Res·2007
3-trial
A low rate of central nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon alfa 2-B for metastatic malignant melanoma.
PMID 16199988·Am J Clin Oncol·2005
3-trial
Inhibition of the epidermal growth factor receptor in combined modality treatment for locally advanced non-small cell lung cancer.
PMID 16015534·Semin Oncol·2005
6-review
Adjuvant high-dose interferon therapy for high-risk melanoma.
PMID 14676083·Arch Dermatol·2003
8-other
Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung cancer.
PMID 14611917·Lung Cancer·2003
6-review
Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients.
PMID 19672942·Cancer·2009
8-other
Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
PMID 19467798·Int J Radiat Oncol Biol Phys·2009
4-observational
Phase I and pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in patients with advanced solid tumors.
PMID 19118068·Clin Cancer Res·2009
3-trial
Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53).
PMID 17657799·Head Neck·2008
3-trial
A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer.
PMID 17399850·Lung Cancer·2007
3-trial
Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses.
PMID 17762436·Am J Clin Oncol·2007
8-other
Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer.
PMID 16878327·Cancer·2006
3-trial
Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer.
PMID 16868164·J Vasc Interv Radiol·2006
8-other
Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer.
PMID 16537876·Chest·2006
8-other
Gefitinib therapy for non-small cell lung cancer.
PMID 15610717·Curr Treat Options Oncol·2005
6-review
Management of unresectable non-small cell carcinoma of the lung (NSCLC).
PMID 14708518·Lung Cancer·2003
8-other
Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancer.
PMID 14708514·Lung Cancer·2003
6-review
A phase I study of a weekly schedule of paclitaxel and carboplatin in patients with advanced carcinoma.
PMID 12404295·Cancer·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4101 N ROXBORO ST
DURHAM, NC 27704 - Phone
- (919) 684-8111
Quick Facts
- NPI
- 1932156197
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile